滕理送附属第一医院 | 医学院临床医学胃肠道恶性肿瘤、甲状腺肿瘤的基础与临床个人简介:求是特聘教授国家临床重点专科（肿瘤学）带头人浙江省中西医结合肿瘤治疗学重点学科带头人    主任医师，教授，博士生导师，现任浙江大学附属第一医院肿瘤外科主任，肿瘤中心主任，浙大医学院临床一系肿瘤学教研室主任。在1987-1990年及1991-1994年攻读硕士和博士学位期间从事光动力学治疗肿瘤研究及大肠癌p53基因实验性基因治疗研究。1997-2000年作为博士后赴美国康乃尔大学医学院/纽约医院从事肿瘤的基因诊断及实验性基因治疗等研究工作。回国至今从事肿瘤的临床科研教学工作及科教管理工作。目前研究方向：胃肠道肿瘤、甲状腺肿瘤、乳腺肿瘤的临床及基础研究（基于恶性肿瘤PDX模型的建立及应用，恶性肿瘤的分子标记物研究，恶性肿瘤的生物治疗）。学术兼职：中国医师协会肿瘤学分会委员浙江省肿瘤学分会副主任委员浙江省抗癌协会肿瘤生物治疗分会副主任委员浙江省抗癌协会肿瘤营养与支持治疗专业委员会主任委员科技部国家自然基金评审专家、国内外多本杂志的编委及特约审稿人（MolecularOncology，BMC Cancer，HBPT int等）教学与课程:共开设课程5门，课程教学时数共计40学时，年均20学时。其中本科生课程3门，课程教学时数24具体开课情况如下：外科学总论（甲）  本科生大类课程    临床七年制本科阶段     80人   6学时   外科学总论（乙）  本科生大类课程    五年制本科             80人   3学时  临床遗传学        本科生专业课程    临床七年制本科阶段     80人   3学时   外科学进展        硕士专业课程      临床七年制硕士阶段     50人   4学时  临床肿瘤学        博士专业课程      肿瘤学博士             25人   4学时研究与成果:主持科研项目：国家自然科学基金项目，81772853，基于能量代谢与PDX模型的甲状腺癌靶向BRAF耐药研究浙江省卫计委省部共建重点项目，2017209495，胃癌精准治疗研究浙江省自然基金重点项目，LZ16H160001，重组痘苗病毒载体表达存活素-端粒酶融合蛋白作为胃癌治疗性活疫苗国家卫计委公益项目，201502027，乳腺增生症诊疗规范的修订十二五国家新药创制重大项目，2013ZX09506015，结直肠癌个体化用药生物标记物的筛选及产业化研究国家卫计委临床重点专科建设，肿瘤学科国家自然科学基金面上项目，81272676，基于PDTT移植瘤的抗肿瘤血管生成靶向治疗弥漫性胃癌的研究浙江省中医药重点学科建设项目，胃癌创新性中西医结合诊治学科浙江省科技厅重大项目，2009C13021，仿真人体的胃癌裸鼠移植瘤模型的建立及其临床应用研究973项目子课题，2009CB521704，肿瘤细胞周期捕获与血管生成的分子基础研究国家自然科学基金面上项目，30772510，新型雌激素受体亚型ER-α36在人乳腺癌中的表达和作用研究浙江省自然科学基金人才项目，R206060，滕理送、曹江、蔡真研究小组863重大项目子课题，2006AA02A245，肿瘤抗体药物国家自然科学基金面上项目，30572155，新型免疫增强型肿瘤裂解病毒的研制973项目子课题 2003CB515507，器官移植术后肿瘤复发的免疫学分子机理及干预策略研究部分奖励荣誉：2017年“仿真人体肿瘤的裸鼠移植瘤模型的建立及其临床应用研究”获浙江省科技进步奖三等奖（排名：1/13）2015年“仿真人体的胃癌裸鼠移植瘤模型的建立及其临床应用研究”获浙江省医药卫生科技奖二等奖（排名：1/16）2005年“供体过继免疫治疗在肝脏移植中应用研究”获浙江省医药卫生科技创新奖一等奖（排名：9/14）2003年“端粒酶在人恶性肿瘤诊断及治疗中的应用研究”获浙江省科学技术奖二等奖（排名：1/9）2003年“端粒酶在人恶性肿瘤诊断及治疗中的应用研究”获浙江省医药卫生科技创新奖一等奖（排名：1/7）2003年“微小肝癌诊治及原发性肝癌预后因素研究”获浙江省科学技术奖三等奖（排名：6/7）2003年“微小肝癌诊治及原发性肝癌预后因素研究”获浙江省医药卫生科技创新奖三等奖（排名：6/9）发表论文:以第一作者或通讯作者发表82篇SCI论文：Chen X Guan Z Lu J Wang H Zuo Z Ye F Huang J Teng L. Synergisticantitumor effects of cMet inhibitor in combination with anti-VEGF in colorectalcancer patient-derived xenograft models.J Cancer.2018 Mar 14;9(7)1207-1217.Yan DF Zhang WB Ke SB Zhao F Yan SX Wang QD Teng LS. The prognosticvalue of pretreatment tumor apparent diffusion coefficient values innasopharyngeal carcinoma. BMC Cancer. 2017 Oct 11;17(1):678.Chen Y Rao X Huang K Jiang X Wang H Teng L. FH535 Inhibits Proliferation and Motility of Colon Cancer Cells by Targeting Wnt/β-catenin Signaling Pathway. J Cancer. 2017 Sep 12;8(16):3142-3153.Wang H Guan Z He K Qian J Cao J Teng L. LncRNA UCA1 in anti-cancer drugresistance. Onco-target. 2017 Jun 2.Gu Y Chen T Li G Xu C Xu Z Zhang J He K Zheng L Guan Z Su X Cao JTeng L. Lower Beclin 1 downregulates HER2 expression to enhance tamoxifensensitivity and predicts a favorable outcome for ER positive breast cancer. Oncotarget.2016 Aug 4;8(32):52156-52177.Yang JS Wu XH Yu HG Teng LS. Tangeretin inhibits neurodegeneration andattenuates inflammatory responses and behavioural deficits in1-methyl-4-phenyl-1236tetrahydropyridine (MPTP)-induced Parkinsons diseasedementia in rats. Inflammopharmacology. 2017 Aug;25(4):471-484 Wang H Lu J Tang J Chen S He K Jiang X Jiang W Teng L. Establishment ofpatient-derived gastric cancer xenografts: a useful tool for preclinicalevaluation of targeted therapies involving alterations in HER-2 MET and FGFR2signaling pathways. BMC Cancer. 2017 Mar 14;17(1):191.    Su X Jiang X Wang W Wang H Xu X Lin A Teng X Wu H Teng L. Association of telomerase reverse transcriptase promoter mutations with clinicopathologicalfeatures and prognosis of thyroid cancer: a meta-analysis. Onco Targets Ther.2016 Nov 11;9:6965-6976.  Su X Wang W Ruan G Liang M Zheng J Chen Y Wu H Fahey TJ Guan M TengL. A Comprehensive Characterization of Mitochondrial Genome in Papillary Thyroid Cancer. Int J Mol Sci. 2016 Oct 10;17(10).      Lu YM Cheng F Teng LS. The association between phosphatase and tensinhomolog hypermethylation and patients with breast cancer a meta-analysis andliterature review. Sci Rep. 2016 Sep 13;6:32723.          Gu Y Chen T Li G Xu C Xu Z Zhang J He K Zheng L Guan Z Su X Cao JTeng L. Lower Beclin 1 downregulates HER2 expression to enhance tamoxifensensitivity and predicts a favorable outcome for ER positive breast cancer.Oncotarget. 2016 Aug 4.  Guo L Zheng J Zhang J Wang H Shao G Teng L. Knockdown of TAZ modifiestriple-negative breast cancer cell sensitivity to EGFR inhibitors by regulatingYAP expression. Oncol Rep. 2016 Aug;36(2):729-36.    Su X Jiang X Xu X Wang W Teng X Shao A Teng L. Diagnostic value of BRAF (V600E)-mutation analysis in fine-needle aspiration of thyroid nodules: ameta-analysis. Onco Targets Ther. 2016 Apr 27;9:2495-509.         Zheng L Xu C Guan Z Su X Xu Z Cao J Teng L. Galectin-1 mediatesTGF-β-induced transformation from normal fibroblasts into carcinoma-associatedfibroblasts and promotes tumor progression in gastric cancer. Am J Transl Res.2016 Apr 15;8(4):1641-58.        Wang W Su X He K Wang Y Wang H Wang H Zhao Y Zhao W Zarnegar R Fahey TJ 3rd Teng X Teng L. Comparison of the clinicopathologic features andprognosis of bilateral versus unilateral multifocal papillary thyroid cancer: An updated study with more than 2000 consecutive patients. Cancer. 2016 Jan15;122(2):198-206..  Wang H Zhang X Teng L Legerski RJ. DNA damage checkpoint recovery andcancer development. Exp Cell Res. 2015 Jun 10;334(2):350-8.  Guo L Teng L. YAP/TAZ for cancer therapy: opportunities and challenges(review). Int J Oncol. 2015 Apr;46(4):1444-52. Yu XF Guo LW Chen ST Teng LS. Gastritis cysticaprofunda in a previouslyunoperated stomach: a case report. World J Gastroenterol. 2015 Mar28;21(12):3759-62.Lu J Li G He K Jiang W Xu C Li Z Wang H Wang W Wang H Teng X TengL. Luteolin exerts a marked antitumor effect in cMet-overexpressingpatient-derived tumor xenograft models of gastric cancer. J Transl Med. 2015 Feb 1;13:42Gao W Liu L Ye G Lu W Teng L. Bilateral areolar approach endoscopicthyroidectomy for low-risk papillary thyroid carcinoma: a review of 137 casescorrected. SurgLaparoscEndoscPercutan Tech. 2015 Feb;25(1):19-22. Gu Y Chen T Fu S Sun X Wang L Wang J Lu Y Ding S Ruan G Teng L WangM. Perioperative dynamics and significance of amino acid profiles in patientswith cancer. J Transl Med. 2015 Jan 27;13:35. Guan Z Yu X Wang H Wang H Zhang J Li G Cao J Teng L. Advances in thetargeted therapy of liposarcoma. Onco Targets Ther. 2015 Jan 5;8:125-36.  Gu Y Chen T Li G Yu X Lu Y Wang H Teng L. LncRNAs: emerging biomarkers in gastric cancer. Future Oncol. 2015;11(17):2427-41.Lu J Gao J Zhang J Sun J Wu H Shi X Teng L Liang Z. Associationbetween BRAF V600E mutation and regional lymph node metastasis in papillarythyroid carcinoma. Int J ClinExpPathol. 2015 Jan 1;8(1):793-9.Xu X Qian LJ Su XY He KF Jin KT Gu LH Feng JG Li GL Zhou Q Xu ZZWang HH Zhang J Cao J Teng LS. Establishment and characterization of GCSR1 a multi-drug resistant signet ring cell gastric cancer cell line. Int J Oncol.2015;46(6):2479-87. Guo L He K Xu X Li G Li Z Xia Y Teng X Teng L. Giant appendicealneurofibroma in von Recklinghausens disease: A case report and literaturereview. Oncol Lett. 2014 Nov;8(5):1957-1960.Su X Xu X Li G Lin B Cao J Teng L. ER-α36: a novel biomarker andpotential therapeutic target in breast cancer. Onco Targets Ther. 2014 Aug30;7:1525-33. doi: 10.2147/OTT.S65345. Review.Yu XF Wang WB Teng XD Wang HY Chen X Wang HH Ma ZM Fahey TJ 3rd TengLS. Clinicopathological and prognostic analysis of follicular thyroid carcinomain a single institute over a 15-year period. Eur J SurgOncol. 2014Jul;40(7):869-74. Li J Teng L Jiang H. Relationship between preoperative serum TSH levels and expression of VEGF in papillary thyroid carcinoma. Asia Pac J ClinOncol. 2014Jun;10(2):149-52. Li G Teng L. A superior strategy for single-cell mutational screening viamultiplex-targeted QPCR using the BioMark HD microfluidic platform. Future Oncol.2014 Mar;10(4):507-10.Wu J Chen QX Teng LS Krasna MJ. Prognostic significance of positivecircumferential resection margin in esophageal cancer: a systematic review andmeta-analysis. Ann Thorac Surg. 2014 Feb;97(2):446-53.Gu Y Chen T López E Wu W Wang X Cao J Teng L. The therapeutic target of estrogen receptor-alpha36 in estrogen-dependent tumors. J Transl Med. 2014 Jan21;12:16.  Yang J Wu X Yu H Liao X Teng L. NMDA receptor-mediated neuroprotectiveeffect of the ScutellariabaicalensisGeorgi extract on the excitotoxic neuronal cell death in primary rat cortical cell cultures. ScientificWorldJournal.2014;2014:459549. Chen X Zhang HB Li ZQ Yu XF Yang MF Wang HH Teng LS. Indocyanine greenclearance in evaluating the recovery of liver reserve function aftersuperselectivetransarterial chemoembolization. Hepatobiliary Pancreat Dis Int.2013 Dec;12(6):656-60.Teng L Lu J. cMET as a potential therapeutic target in gastric cancer(Review). Int J Mol Med. 2013 Dec;32(6):1247-54.  Hua H Chen W Shen L Sheng Q Teng L. Honokiol augments the anti-cancereffects of oxaliplatin in colon cancer cells. ActaBiochimBiophysSin(Shanghai). 2013 Sep;45(9):773-9.Ma WJ Wang HY Teng LS. Correlation analysis of preoperative serumalpha-fetoprotein (AFP) level and prognosis of hepatocellular carcinoma (HCC)after hepatectomy. World J SurgOncol. 2013 Aug 27;11:212.  Li G Zhang J Jin K He K Zheng Y Xu X Wang H Wang H Li Z Yu X TengXCao J Teng L. Estrogen receptor-α36 is involved in development of acquiredtamoxifen resistance via regulating the growth status switch in breast cancercells. MolOncol. 2013 Jun;7(3):611-24.    5.367  Yu Q Yu XF Zhang SD Wang HH Wang HY Teng LS. Prognostic role ofC-reactive protein in gastric cancer: a meta-analysis. Asian Pac J Cancer Prev.2013;14(10):5735-40.   Lan H Zheng L Jin K Teng L. Antitumor effect of FP3 in a breast cancerxenograft model. ExpTher Med. 2013 Jan;5(1):85-88.  Lan H Jin K Xie B Han N Cui B Cao F Teng L. Heterogeneity betweenprimary colon carcinoma and paired lymphatic and hepatic metastases. Mol Med Rep.2012 Nov;6(5):1057-68.Wu J Chen QX Zhou XM Mao WM Krasna MJ Teng LS. Prognostic significance ofsolitary lymph node metastasis in patients with squamous cell carcinoma of middlethoracic esophagus. World J SurgOncol. 2012 Oct 4;10:210. doi:10.1186/1477-7819-10-210. PubMedJiang WQ Fu FF Li YX Wang WB Wang HH Jiang HP Teng LS. Molecularbiomarkers of colorectal cancer: prognostic and predictive tools for clinicalpractice. J Zhejiang UnivSci B. 2012 Sep;13(9):663-75. Dong X Jin K Hu X Du F Lan H Han N Ma Z Xie B Cui B Teng L Cao F.Antitumor effect of FP3 in combination with cetuximab on patient-derived tumortissue xenograft models of primary colon carcinoma and related lymphatic and hepatic metastases. Int J Mol Med. 2012 Jul;30(1):126-32.  Jiang W Wang W Fu F Teng X Wang H Wang H Teng L. A more sensitiveplatform for the detection of low-abundance BRAF(V⁶⁰⁰E) mutations. Mol CellBiochem. 2012 Jul;366(1-2):49-58. He K Jin K Wang H Teng L. Anti-angiogenic therapy for colorectal cancer: onthe way to getting better! Hepatogastroenterology. 2012 Jun;59(116):1113-7.  Deng J Fang WJ Zhang XC Wu DP Fang HM Chen J Qian J Mou HB Chu BB Xu N Teng LS. Phase II trial of gefitinib in pretreated Chinese women with advancednon-small-cell lung cancer. Med Oncol. 2012 Jun;29(2):595-9.Gao W Jin K Lan H Han N Cao F Teng L. FP3: a novel VEGF blocker withanti-angiogenic and anti-tumor effects. Hepatogastroenterology. 2012Nov-Dec;59(120):2543-7. He K Cui B Li G Wang H Jin K Teng L. The effect of anti-VEGF drugs(bevacizumab and aflibercept) on the survival of patients with metastaticcolorectal cancer (mCRC). Onco Targets Ther. 2012;5:59-65.Jin K Gao W Lu Y Lan H Teng L Cao F. Mechanisms regulating colorectalcancer cell metastasis into liver (Review). Oncol Lett. 2012 Jan;3(1):11-15.  Lv K Liu L Wang L Yu J Liu X Cheng Y Dong M Teng R Wu L Fu P Deng WHu W Teng L. Lin28 mediates paclitaxel resistance by modulating p21 Rb andLet-7a miRNA in breast cancer cells. PLoS One. 2012;7(7):e40008. Mou X Chen L Liu F Lin J Diao P Wang H Li Y Lin J Teng L Xiang C.Prevalence of JC virus in Chinese patients with colorectal cancer. PLoS One.2012;7(5):e35900.  Jin K Lan H Cao F Xu Z Han N Li G He K Teng L. Antitumor effect of FP3 in a patient-derived tumor tissue xenograft model of gastric carcinoma through anantiangiogenic mechanism. Oncol Lett. 2012 May;3(5):1052-1058.Zhang J Li G Li Z Yu X Zheng Y Jin K Wang H Gong Y Sun X Teng X Cao J Teng L. Estrogen-independent effects of ER-α36 in ER-negative breast cancer.Steroids. 2012 May;77(6):666-73. Wang W Zhao W Wang H Teng X Wang H Chen X Li Z Yu X Fahey TJ 3rdTeng L. Poorer prognosis and higher prevalence of BRAF (V600E) mutation insynchronous bilateral papillary thyroid carcinoma. Ann SurgOncol. 2012Jan;19(1):31-6. Jin K He K Teng F Li G Wang H Han N Xu Z Cao J Wu J Yu D Teng L.FP3: a novel VEGF blocker with antiangiogenic effects in vitro and antitumoureffects in vivo. ClinTranslOncol. 2011 Dec;13(12):878-84.Han N Jin K He K Cao J Teng L. Protease-activated receptors in cancer: Asystematic review. Oncol Lett. 2011 Jul;2(4):599-608.Li G Zhang J Jin K He K Wang H Lu H Teng L. Human mammaglobin: asuperior marker for reverse-transcriptase PCR in detecting circulating tumorcells in breast cancer patients. Biomark Med. 2011 Apr;5(2):249-60.Jin K Lan H Zhu T He K Teng L. Gallbladder carcinoma incidentallyencountered during laparoscopic cholecystectomy: how to deal with it. ClinTranslOncol. 2011 Jan;13(1):25-33.Jin K He K Han N Li G Wang H Xu Z Jiang H Zhang J Teng L.Establishment of a PDTT xenograft model of gastric carcinoma and its application in personalized therapeutic regimen selection. Hepatogastroenterology. 2011Sep-Oct;58(110-111):1814-22. Li Z Jin K Lan H Teng L. Heterogeneity in primary colorectal cancer and itscorresponding metastases: a potential reason of EGFR-targeted therapy failure? Hepatogastroenterology. 2011 Mar-Apr;58(106):411-6. Mou X Chen L Liu F Shen Y Wang H Li Y Yuan L Lin J Lin J TengLXiang C. Low prevalence of human papillomavirus (HPV) in Chinese patients withbreast cancer. J Int Med Res. 2011;39(5):1636-44.Teng LS Jin KT He KF Zhu TM Zhao F Jin ZG. Bilateral massive ovarianluteinized follicular cysts of a twin pregnancy. J Chin Med Assoc. 2010Dec;73(12):644-6.1.252Wang W Wang H Teng X Wang H Mao C Teng R Zhao W Cao J Fahey TJ 3rdTeng L. Clonal analysis of bilateral recurrent and metastatic papillary thyroidcarcinomas. Hum Pathol. 2010 Sep;41(9):1299-309. 3.014Teng LS Jin KT He KF Zhang J Wang HH Cao J. Clinical applications ofVEGF-trap (aflibercept) in cancer treatment. J Chin Med Assoc. 2010Sep;73(9):449-56.Li ZQ Wang HY Li J Teng L. Recurrent retroperitoneal Schwannomas displayingdifferent differentiation from primary tumor: case report and literature review. World J SurgOncol. 2010 Aug 9;8:66. Jin K Shen Y He K Xu Z Li G Teng L. Aflibercept (VEGF Trap): one moredouble-edged sword of anti-VEGF therapy for cancer? ClinTranslOncol. 2010Aug;12(8):526-32. Teng LS Jin KT Han N Cao J. Radiofrequency ablation heat shock protein 70 and potential anti-tumor immunity in hepatic and pancreatic cancers: aminireview. Hepatobiliary Pancreat Dis Int. 2010 Aug;9(4):361-5. Review. PubMedPMID: 20688598.Jin K Teng L Shen Y He K Xu Z Li G. Patient-derived human tumour tissue xenografts in immunodeficient mice: a systematic review. ClinTranslOncol. 2010 Jul;12(7):473-80.2.353Teng LS Jin KT He KF Wang HH Cao J Yu DC. Advances in combination ofantiangiogenic agents targeting VEGF-binding and conventional chemotherapy andradiation for cancer treatment. J Chin Med Assoc. 2010 Jun;73(6):281-8.  Zheng Y Zhang J Xu ZZ Sheng JM Zhang XC Wang HH Teng XD Liu XJ Cao J Teng LS. Quantitative profiles of the mRNAs of ER-alpha and its novel variantER-alpha36 in breast cancers and matched normal tissues. J Zhejiang UnivSci B.2010 Feb;11(2):144-50.Teng L Jin K He K Bian C Chen W Fu K Zhu T Jin Z. Use of complementary and alternative medicine by cancer patients at Zhejiang University TeachingHospital Zhuji Hospital China. Afr J Tradit Complement Altern Med.2010;7(4):322-30.Wang HH Wang YX Griffith JF Sun YL Zhang G Chan CW Qin L Ahuja AT TengLS. Pitfalls in interpreting rat knee joint magnetic resonance images and theirhistological correlation. ActaRadiol. 2009 Nov;50(9):1042-8. Mao CY Hua HJ Chen P Yu DC Cao J Teng LS. Combined use ofchemotherapeutics and oncolytic adenovirus in treatment of AFP-expressinghepatocellular carcinoma. Hepatobiliary Pancreat Dis Int. 2009 Jun;8(3):282-7.  Wang HH Wang YX Sheng H Zhang G Qin L Ahuja AT Teng LS. Fossatrochanterica of the proximal femur in rabbits: an anatomic structure forpotential misinterpretation on magnetic resonance images. ActaRadiol. 2009Mar;50(2):212-6. Teng LS Zheng Y Zhang J. Neoadjuvant chemotherapy for metastatic colorectal cancer to the liver: from chemotherapy to targeting therapy. HepatobiliaryPancreat Dis Int. 2008 Dec;7(6):569-70.  Teng LS Zheng Y Wang HH. BRCA1/2 associated hereditary breast cancer. JZhejiang UnivSci B. 2008 Feb;9(2):85-9.78.    Jiang HP Teng RY Wang Q Zhang X Wang HH Cao J Teng LS. Estrogen receptoralpha variant ERalpha46 mediates growth inhibition and apoptosis of human HT-29colon adenocarcinoma cells in the presence of 17beta-oestradiol. Chin Med J(Engl). 2008 Jun 5;121(11):1025-31.Jiang H Teng R Wang Q Zhang X Wang H Wang Z Cao J Teng L.Transcriptional analysis of estrogen receptor alpha variant mRNAs in colorectalcancers and their matched normal colorectal tissues. J Steroid BiochemMol Biol. 2008 Nov;112(1-3):20-4. Wang HH Mao CY Teng LS Cao J. Recent advances in heat shock protein-based cancer vaccines. Hepatobiliary Pancreat Dis Int. 2006 Feb;5(1):22-7.Teng LS Fahey TJ 3rd. Can inhibition of telomerase increase pancreaticcancer cells susceptibility to chemotherapeutic reagents? Hepatobiliary PancreatDis Int. 2002 Feb;1(1):155-60.Teng L Chen S Thomas J F. Stable expression of antisense hTR inhibits invitro pancreatic cancer cell growth. Chin Med J (Engl). 2002 Aug;115(8):1196-200.   实验室介绍:栏目建设中....